| Financial Year |
March 31 2023 |
| Monetary Funds |
3,985,177,007.77 |
| Held-for-trading Financial Assets |
1,041,318,263.35 |
| Notes Receivable |
194,990,818.12 |
| Accounts Receivable |
1,201,276,022.42 |
| Advances to Suppliers |
1,180,928,709.72 |
| Other Receivables |
762,542,717.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,325,216,106.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,868,801,353.07 |
| Total Current Assets |
17,602,060,506.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,249,232.53 |
| Long-term Equity Investment |
434,163,330.68 |
| Investment Properties |
46,707,013.93 |
| Fixed Assetes |
8,244,741,917.88 |
| Under-construction Projects |
1,093,936,241.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,689,455,880.28 |
| R&D expenses |
1,229,471.68 |
| Goodwill |
1,061,001,248.93 |
| Long-Term Deferred and Prepaid Expenses |
216,040,392.60 |
| Deferred Income Tax Assets |
447,043,819.15 |
| Other Non-Current Assets |
538,297,091.24 |
| Sub-Total of Non-Current Assets |
16,139,404,145.69 |
| Total Assets |
33,741,464,652.21 |
| Short-Term Loans |
5,075,179,318.54 |
| Trading Financial liabilities |
32,316,159.36 |
| Notes Payable |
2,822,444,376.92 |
| Accounts Payable |
2,068,546,777.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
58,781,477.69 |
| Taxes Payable |
85,457,304.90 |
| Interest Payable |
57,058,224.06 |
| Dividend Payable |
-- |
| Other payables |
1,284,697,426.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
577,868,264.88 |
| Other Current Liabilities |
223,917,024.44 |
| Sub-Total of Current Liabilities |
13,922,869,809.84 |
| Long-term Loans |
1,610,110,917.81 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
448,082,368.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
63,192,931.14 |
| Deferred Income Tax Liabilities |
673,752,418.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,808,171,082.77 |
| Total Liabilities |
16,731,040,892.61 |
| Paid-In Capital(Or Share Stock) |
3,141,203,280.00 |
| Capital Surplus |
8,857,579,919.11 |
| Surplus Reserve |
174,821,015.29 |
| LESS:Treasury Stock |
76,160,820.00 |
| Undistributed Profits |
2,208,290,822.69 |
| Minority Stockholder's Interest |
2,931,004,225.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,079,419,534.02 |
| Owner's Equity（Stockholder's Equity） |
17,010,423,759.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
33,741,464,652.21 |
